Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines in some countries that treat the underlying causes of cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia and continues to advance its research in these and other diseases.